Regent Pacific Group Limited (HKG:0575)

Hong Kong · Delayed Price · Currency is HKD

1.010

+0.030 (3.06%)

Jun 22, 2026, 3:40 PM HKT

-3.81% (1Y)

Market Cap	285.98M +21.5%
Revenue (ttm)	2.83M -49.5%
Net Income	-36.66M
EPS	-0.14
Shares Out	291.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,413,739
Open	0.950
Previous Close	0.980
Day's Range	0.880 - 1.130
52-Week Range	0.570 - 1.220
Beta	1.19
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1991

Employees 16

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 0575

Full Company Profile

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD Financial Statements